RAFAEL HOLDINGS, INC. Available-for-sale Securities, Gross Unrealized Loss
RAFAEL HOLDINGS, INC. (RFL) reported Available-for-sale Securities, Gross Unrealized Loss of $2.00 thousand for the 3-month period ending 2018-10-31, per its 10-Q filed 2018-12-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2019-10-04
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross unrealized loss for the quarter ending 2018-10-31 was $2.00K.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross unrealized loss for the quarter ending 2018-07-31 was $351.00K.
- RAFAEL HOLDINGS, INC. available-for-sale securities, gross unrealized loss for fiscal 2018 was $40.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 6 month | Available-for-sale Securities, Gross Unrealized Loss 9 month | Available-for-sale Securities, Gross Unrealized Loss 12 month | Available-for-sale Securities, Gross Unrealized Loss 12 month as first filed |
|---|---|---|---|---|---|
| 2018-10-31 | $2.00K 10-Q · filed 2018-12-10 | $353.00K derived: sum of 2 quarters · filed 2019-10-04 | |||
| 2018-07-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $40.00K 10-K · filed 2019-10-04 | $309.00K 10-K · filed 2018-10-15 | ||
| 2018-04-30 | -$311.00K 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |